MatriSys Bioscience
La Jolla, US · Delaware corporation
Founders & leadership
MM
Magda MarquetNamed on SEC filing
PC
Philippe CalaisNamed on SEC filing
CN
Carey NgNamed on SEC filing
JM
James MackayNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$8.4M disclosed across 1 round · 2022
▶$8.4MraisedJul 2022 · 49 investors · BiotechnologyRule 506(b)
▶$8.4MraisedJul 2022 · 49 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Magda MarquetDirector
- Philippe CalaisExecutive Officer, Director
- Carey NgDirector
- James MackayDirector
- Offering amount
- $61.7M
- Amount sold
- $8.4M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has MatriSys Bioscience raised?
- MatriSys Bioscience has disclosed $8.4M raised across 1 round.
- Where is MatriSys Bioscience headquartered?
- MatriSys Bioscience is headquartered in La Jolla, US.